Hong Kong · Delayed Price · Currency is HKD Peijia Medical Statistics
Total Valuation
Peijia Medical has a market cap or net worth of HKD 3.24 billion. The enterprise value is 3.13 billion.
| Market Cap | 3.24B |
| Enterprise Value | 3.13B |
Important Dates
The next estimated earnings date is Friday, November 20, 2026.
| Earnings Date | Nov 20, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Peijia Medical has 672.63 million shares outstanding. The number of shares has increased by 0.69% in one year.
| Current Share Class | 672.63M |
| Shares Outstanding | 672.63M |
| Shares Change (YoY) | +0.69% |
| Shares Change (QoQ) | +0.87% |
| Owned by Insiders (%) | 3.07% |
| Owned by Institutions (%) | 12.32% |
| Float | 419.40M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 582.25 |
| PS Ratio | 3.57 |
| PB Ratio | 1.51 |
| P/TBV Ratio | 2.40 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 111.17 |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 3.45 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.56, with a Debt / Equity ratio of 0.35.
| Current Ratio | 1.56 |
| Quick Ratio | 1.24 |
| Debt / Equity | 0.35 |
| Debt / EBITDA | n/a |
| Debt / FCF | -8.70 |
| Interest Coverage | -6.54 |
Financial Efficiency
Return on equity (ROE) is -7.60% and return on invested capital (ROIC) is -2.52%.
| Return on Equity (ROE) | -7.60% |
| Return on Assets (ROA) | -2.20% |
| Return on Invested Capital (ROIC) | -2.52% |
| Return on Capital Employed (ROCE) | -4.42% |
| Weighted Average Cost of Capital (WACC) | 6.55% |
| Revenue Per Employee | 876,183 |
| Profits Per Employee | -157,573 |
| Employee Count | 1,033 |
| Asset Turnover | 0.28 |
| Inventory Turnover | 1.77 |
Taxes
In the past 12 months, Peijia Medical has paid 15.15 million in taxes.
| Income Tax | 15.15M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -23.89% in the last 52 weeks. The beta is 0.62, so Peijia Medical's price volatility has been lower than the market average.
| Beta (5Y) | 0.62 |
| 52-Week Price Change | -23.89% |
| 50-Day Moving Average | 4.81 |
| 200-Day Moving Average | 5.47 |
| Relative Strength Index (RSI) | 46.76 |
| Average Volume (20 Days) | 500,802 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Peijia Medical had revenue of HKD 905.10 million and -162.77 million in losses. Loss per share was -0.24.
| Revenue | 905.10M |
| Gross Profit | 610.10M |
| Operating Income | -112.21M |
| Pretax Income | -153.39M |
| Net Income | -162.77M |
| EBITDA | -36.91M |
| EBIT | -112.21M |
| Loss Per Share | -0.24 |
Balance Sheet
The company has 878.69 million in cash and 753.51 million in debt, with a net cash position of 125.18 million or 0.19 per share.
| Cash & Cash Equivalents | 878.69M |
| Total Debt | 753.51M |
| Net Cash | 125.18M |
| Net Cash Per Share | 0.19 |
| Equity (Book Value) | 2.14B |
| Book Value Per Share | 3.16 |
| Working Capital | 457.92M |
Cash Flow
In the last 12 months, operating cash flow was 29.10 million and capital expenditures -115.69 million, giving a free cash flow of -86.58 million.
| Operating Cash Flow | 29.10M |
| Capital Expenditures | -115.69M |
| Depreciation & Amortization | 76.33M |
| Net Borrowing | 386.99M |
| Free Cash Flow | -86.58M |
| FCF Per Share | -0.13 |
Margins
Gross margin is 67.41%, with operating and profit margins of -12.40% and -17.98%.
| Gross Margin | 67.41% |
| Operating Margin | -12.40% |
| Pretax Margin | -16.95% |
| Profit Margin | -17.98% |
| EBITDA Margin | -4.08% |
| EBIT Margin | -12.40% |
| FCF Margin | n/a |
Dividends & Yields
Peijia Medical does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -0.69% |
| Shareholder Yield | -0.69% |
| Earnings Yield | -5.03% |
| FCF Yield | -2.68% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Analyst Forecast
The average price target for Peijia Medical is 9.81, which is 103.95% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | 9.81 |
| Price Target Difference | 103.95% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 4 |
| Revenue Growth Forecast (3Y) | 27.84% |
| EPS Growth Forecast (3Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 3 |